MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) by 135.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 752,335 shares of the company's stock after purchasing an additional 432,206 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. owned approximately 1.20% of Bioceres Crop Solutions worth $4,574,000 as of its most recent SEC filing.
Several other large investors also recently modified their holdings of BIOX. Bank of America Corp DE raised its position in shares of Bioceres Crop Solutions by 186.8% in the fourth quarter. Bank of America Corp DE now owns 5,735 shares of the company's stock valued at $35,000 after purchasing an additional 3,735 shares during the period. Jump Financial LLC bought a new position in shares of Bioceres Crop Solutions in the fourth quarter valued at about $72,000. Northern Trust Corp bought a new position in shares of Bioceres Crop Solutions in the fourth quarter valued at about $93,000. Ping Capital Management Inc. raised its position in shares of Bioceres Crop Solutions by 7.3% in the fourth quarter. Ping Capital Management Inc. now owns 44,000 shares of the company's stock valued at $268,000 after purchasing an additional 3,000 shares during the period. Finally, Stifel Financial Corp raised its position in shares of Bioceres Crop Solutions by 51.9% in the fourth quarter. Stifel Financial Corp now owns 61,958 shares of the company's stock valued at $377,000 after purchasing an additional 21,168 shares during the period. 17.68% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on BIOX shares. Canaccord Genuity Group dropped their price objective on shares of Bioceres Crop Solutions from $7.00 to $6.50 and set a "buy" rating on the stock in a research report on Thursday, February 13th. Oppenheimer lowered their price target on shares of Bioceres Crop Solutions from $8.00 to $7.00 and set an "outperform" rating on the stock in a research report on Tuesday, April 22nd. Finally, Lake Street Capital lowered their price target on shares of Bioceres Crop Solutions from $13.00 to $8.00 and set a "buy" rating on the stock in a research report on Friday, February 7th. Four analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Buy" and a consensus price target of $8.63.
Read Our Latest Stock Report on BIOX
Bioceres Crop Solutions Trading Up 2.2%
Shares of Bioceres Crop Solutions stock traded up $0.10 during trading on Friday, hitting $4.63. The company's stock had a trading volume of 233,621 shares, compared to its average volume of 173,102. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.33 and a quick ratio of 0.96. Bioceres Crop Solutions Corp. has a 52 week low of $3.51 and a 52 week high of $11.86. The stock has a market cap of $290.35 million, a price-to-earnings ratio of 231.62 and a beta of 0.40. The stock has a 50-day moving average price of $4.35 and a two-hundred day moving average price of $5.47.
Bioceres Crop Solutions (NASDAQ:BIOX - Get Free Report) last issued its quarterly earnings data on Wednesday, May 21st. The company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.10) by $0.08. Bioceres Crop Solutions had a net margin of 0.58% and a return on equity of 0.68%. The company had revenue of $59.60 million for the quarter, compared to analysts' expectations of $61.80 million. Equities research analysts anticipate that Bioceres Crop Solutions Corp. will post -0.05 EPS for the current fiscal year.
Bioceres Crop Solutions Company Profile
(
Free Report)
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
See Also

Before you consider Bioceres Crop Solutions, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioceres Crop Solutions wasn't on the list.
While Bioceres Crop Solutions currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.